BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Brian Mueller , Executive Vice President, Chief Financial Officer, will participate in Morningstar’s Management Behind the Moat Conference on Septem
|
SAN RAFAEL, Calif., Sept. 29, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. Inc. (NASDAQ: BMRN) today announced that Brian Mueller, Executive Vice President, Chief Financial Officer, will participate in Morningstar's Management Behind the Moat Conference on September 30, 2020 at 1:00pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
SOURCE BioMarin Pharmaceutical Inc. |
||||||||||||
Company Codes: NASDAQ-NMS:BMRN |
View original content to download multimedia:
